End-stage renal disease
Conditions
Interventions
None listed
Sponsors
Hakodate Goryoukaku Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients newly introduced to HD or PD 2)Patients who are 75 years or older, without regard to sex 3)Patients who chose renal replacement therapy by SDM(shared decision making) 4)Patients who are anticipated to have stable symptoms during hospitalization 5)Patients who have signed written informed consent for this study
Exclusion criteria
Exclusion criteria: 1)Patients who prognosis is within 5 years and have clinically important complications, including malignant tumors or others 2)Patients who have malignant tumors while being treated with a carcinostatic agent or radiation therapy 3)Patients who are expected to progressively worsen in their general condition due to the progression of complications 4)Patients who are deemed to have a considerably low cognitive ability 5)Patients with already markedly poor general condition at introduction time 6)Patients judged unsuitable for inclusion by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of both BI and KPS every 3 months for 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Change of HDS-R every 6 month for 2 years 2)Change of Zarit Burden Interview(ZBI) every 6 month for 2 years based on presence or absence of visiting nursing 3)Monitoring of laboratory date every 3 months for 2 years 4)Death and cause of death 5)Hospital readmission, cause of rehospitalization, duration of rehospitalization, date and time in the termination of PD/HD, reason for termination of HD/PD | — |
Countries
Japan
Contacts
Public ContactMayumi Yoshihara
Hakodate Goryoukaku Hospital nephrology
Outcome results
None listed